As we got through the height of the pandemic in 2021 and moved into 2022, we believed that it would be a year of hope. And thanks to the support […]
2022 Wrap Up
Holiday Season Carb Counting
It’s the holiday season, and for most people that means indulging in seasonal treats and meals. It’s no different for people living with type 1 diabetes (T1D). One of the […]
The BETTER project is now available across Canada
In November, to celebrate World Diabetes Day, the BETTER (BEhaviors, Therapies, TEchnologies and hypoglycemic Risk in Type 1 diabetes) project announced that it is now the first registry of people […]
Holiday gift guide for people living with type 1 diabetes
The holiday season is fast approaching, and you’re probably putting together your lists to choose the perfect gifts for the people in your life. Why not let JDRF help with […]
Kids For A Cure 2022
JDRF’s Kids For a Cure advocacy event was held from November 13- 15 in Ottawa and what an impact our youth delegates made – engaging with more than 55 Members […]
The Turner family wants to help families like theirs affected by T1D
A diagnosis of type 1 diabetes (T1D) changes the trajectory of an entire family. This was no different for the Turner Family when Alex was diagnosed at 14-years-old. The Turners […]
JDRF Centre of Excellence at UBC celebrates 1 year of progress in T1D cure research
December 2021 marked the launch of the JDRF Centre of Excellence at the University of British Columbia (UBC). One year later, a team of over 40 researchers convened in person […]
Teplizumab approved for use in people at risk of type 1 diabetes by the US Food and Drug Administration
This is the first therapeutic on the market that may help delay the onset of clinicaltype 1 diabetes November 17, 2022 Today, the U.S. Food and Drug Administration (FDA) weighed […]
The Sun Life Ride to Defeat Diabetes was back in-person and an enormous success!
One of Canada’s longest running and top fundraising events returned to in-person Rides in Montréal and Toronto, on October 6 and 13, 2022 respectively, along with virtual rides across the country. […]
New Drug to Prevent Hypoglycemia Enters Clinical Trials
Low blood sugar, called hypoglycemia, is a real fear for people with type 1 diabetes (T1D). Although there are rescue treatments for it, such as injectable or nasal glucagon (Baqsimi), there are currently no preventive therapies available. Canadian company Zucara Therapeutics, however, may have an answer.
Halloween Guide
For many families newly diagnosed with type 1 diabetes (T1D), Halloween can feel overwhelming – a holiday centered on candy when you’re just figuring out carb counting and nutrition. However, […]
Important update on teplizumab – a therapeutic that may help delay the onset of type 1 diabetes
A key tenet of JDRF’s research funding strategy is that there are multiple pathways to cures for type 1 diabetes (T1D), one of which includes screening for risk and use […]
